Carl Schmid discusses NC Blue Cross Blue Shield’s decision to remove HIV drugs from the highest and costliest drug tiers following a discrimination complaint filed by the HIV+Hepatitis Policy Institute and NC AIDS Action Network.
Carl Schmid and Kevin Herwig offer updates at USCHA on Braidwood v Becerra, which challenges ACA’s preventive services coverage requirement, and discuss the amicus brief filed by HIV+Hepatitis Policy Institute and supported by 24 HIV and hepatitis organizations and other amici briefs filed by other groups.
Carl Schmid of the HIV+Hepatitis Policy Institute joins Hannah Lynch, Associate Director, U.S. Public Policy at UCB, to discuss how we can evolve the healthcare system to better serve people living with severe diseases and help them overcome access barriers.
Carl Schmid speaks with “Houston Matters” radio, along with a San Antonio, Texas PrEP client, about private insurers continuing to charge cost-sharing for PrEP and associated services and its impact on PrEP uptake.
Carl Schmid and Dr. Milgram discusses the disparities in education and access to PrEP in the patient populations that need these medications the most.